Organigram Holdings Inc. (
TSE:OGI -
Get Free Report) shares dropped 0.5% during trading on Friday . The stock traded as low as C$2.01 and last traded at C$2.07. Approximately 50,748 shares were traded during mid-day trading, a decline of 71% from the average daily volume of 175,631 shares. The stock had previously closed at C$2.08.
Organigram Stock Down 0.5%
The company has a quick ratio of 2.62, a current ratio of 3.36 and a debt-to-equity ratio of 3.07. The company has a market cap of C$255.73 million, a P/E ratio of -4.38, a price-to-earnings-growth ratio of 0.42 and a beta of 1.13. The company has a fifty day moving average of C$1.91 and a 200 day moving average of C$1.80.
About Organigram
(
Get Free Report)
Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Organigram, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list.
While Organigram currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.